메뉴 건너뛰기




Volumn 27, Issue 8, 2012, Pages 564-582

Anticholinergic burden: Clinical implications for seniors and strategies for clinicians

Author keywords

Adverse drug events; Anticholinergic; Antimuscarinic; Elderly; Geriatric; Older adult

Indexed keywords

AMITRIPTYLINE; CARISOPRODOL; CHLORPHENIRAMINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; CYCLOBENZAPRINE; DARIFENACIN; DICYCLOVERINE; DIPHENHYDRAMINE; DOXEPIN; HYDROXYZINE; HYOSCYAMINE; IMIPRAMINE; IPRATROPIUM BROMIDE; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC M4 RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; OLANZAPINE; OXYBUTYNIN; PIRENZEPINE; SCOPOLAMINE; SOLIFENACIN; THIORIDAZINE; TIOTROPIUM BROMIDE; TOLTERODINE; TROSPIUM CHLORIDE; UNINDEXED DRUG;

EID: 84864579876     PISSN: 08885109     EISSN: None     Source Type: Journal    
DOI: 10.4140/TCP.n.2012.564     Document Type: Review
Times cited : (21)

References (85)
  • 1
    • 58849121855 scopus 로고    scopus 로고
    • Use of drugs with anticholinergic effects and cognitive impairment in communityliving older persons
    • Merchant RA, Li B, Yap KB et al. Use of drugs with anticholinergic effects and cognitive impairment in communityliving older persons. Age Ageing 2009;38:105-8.
    • (2009) Age Ageing , vol.38 , pp. 105-108
    • Merchant, R.A.1    Li, B.2    Yap, K.B.3
  • 3
    • 0034795320 scopus 로고    scopus 로고
    • Anticholinergic effects of medication in elderly patients
    • Tune LE. Anticholinergic effects of medication in elderly patients. J Clin Psychiatry 2001;62 (suppl 21:11-4).
    • (2001) J Clin Psychiatry , vol.62 , Issue.SUPPL. 21 , pp. 11-14
    • Tune, L.E.1
  • 5
    • 13444311773 scopus 로고    scopus 로고
    • Drugs with anticholinergic properties and cognitive performance in the elderly: Results from the PAQUID study
    • Lechevallier-Michel N, Molimard M, Dartigues J et al. Drugs with anticholinergic properties and cognitive performance in the elderly: results from the PAQUID study. Br J Clin Pharmacol 2004;59 [?]2:143-51.
    • (2004) Br J Clin Pharmacol , vol.59 , Issue.2 , pp. 143-151
    • Lechevallier-Michel, N.1    Molimard, M.2    Dartigues, J.3
  • 6
    • 0345304274 scopus 로고    scopus 로고
    • Muscarinic acetylcholine receptor subtypes in cerebral cortex and hippocampus
    • DOI 10.1016/S0079-6123(03)45003-6
    • Volpicelli LA, Levey AI. Muscarinic acetylcholine receptor subtypes in cerebral cortex and hippocampus. Prog Brain Res 2004;145:59-66. (Pubitemid 37442934)
    • (2004) Progress in Brain Research , vol.145 , pp. 59-66
    • Volpicelli, L.A.1    Levey, A.I.2
  • 9
    • 0027636902 scopus 로고
    • The problems of anticholinergic adverse effects in older patients
    • Fienberg M. The problems of anticholinergic adverse effects in older patients. Drugs Aging 1993;3:335-48.
    • (1993) Drugs Aging , vol.3 , pp. 335-348
    • Fienberg, M.1
  • 10
    • 32444441009 scopus 로고    scopus 로고
    • Using anticholinergics to treat overactive bladder: The issue of treatment tolerability
    • DOI 10.1016/j.amjmed.2005.12.011, PII S0002934305011915
    • Staskin DR, MacDiarmid SA. Using anticholinergics to treat overactive bladder: the issue of treatment tolerability. Am J Med 2006;119:9S-15S. (Pubitemid 43227968)
    • (2006) American Journal of Medicine , vol.119 , Issue.3 SUPPL. 1
    • Staskin, D.R.1    MacDiarmid, S.A.2
  • 11
    • 0033803794 scopus 로고    scopus 로고
    • Anticholinergic side-effects of drugs in elderly people
    • Mintzer J, Burns A. Anticholinergic side-effects of drugs in elderly people. J R Soc Med 2000;93:457-62.
    • (2000) J R Soc Med , vol.93 , pp. 457-462
    • Mintzer, J.1    Burns, A.2
  • 12
    • 14844320094 scopus 로고    scopus 로고
    • Antimuscarinic agents: Implications and concerns in the management of overactive bladder in the elderly
    • DOI 10.1016/S0149-2918(05)80030-X
    • Kay GG, Granville LJ. Antimuscarinic agents: implications and concerns in the management of overactive bladder in the elderly. Clin Ther 2005;27:127-38. (Pubitemid 40342583)
    • (2005) Clinical Therapeutics , vol.27 , Issue.1 , pp. 127-138
    • Kay, G.G.1    Granville, L.J.2
  • 13
    • 0027516527 scopus 로고
    • Anticholinergic drug use and bowel function in nursing home patients
    • DOI 10.1001/archinte.153.5.633
    • Monane M, Avorn J, Beers M et al. Anticholinergic drug use and bowel function in nursing home patients. Arch Intern Med 1993;153:633-8. (Pubitemid 23072392)
    • (1993) Archives of Internal Medicine , vol.153 , Issue.5 , pp. 633-638
    • Monane, M.1    Avorn, J.2    Beers, M.H.3    Everitt, D.E.4
  • 15
    • 0026352230 scopus 로고
    • Anticholinergic challenge and cognitive functions: A comparison between young and elderly normal subjects
    • Zemishlany Z, Thorne AE. Anticholinergic challenge and cognitive functions: a comparison between young and elderly normal subjects. Isr J Psychiatry Relat Sci 1991;8:32-41.
    • (1991) Isr J Psychiatry Relat Sci , vol.8 , pp. 32-41
    • Zemishlany, Z.1    Thorne, A.E.2
  • 16
    • 0037315114 scopus 로고    scopus 로고
    • Serum anticholinergic activity in a community-based sample of older adults
    • Mulsant BH, Pollock BG, Kirshner M et al. Serum anticholinergic activity in a community-based sample of older adults. Arch Gen Psychiatry 2003;60:198-203.
    • (2003) Arch Gen Psychiatry , vol.60 , pp. 198-203
    • Mulsant, B.H.1    Pollock, B.G.2    Kirshner, M.3
  • 17
    • 48449102484 scopus 로고    scopus 로고
    • Anticholinergic activity of 107 medications commonly used in older adults
    • Chew ML, Mulsant BH, Pollock BG et al. Anticholinergic activity of 107 medications commonly used in older adults. J Am Geriatr Soc 2008;56:1333-41.
    • (2008) J Am Geriatr Soc , vol.56 , pp. 1333-1341
    • Chew, M.L.1    Mulsant, B.H.2    Pollock, B.G.3
  • 18
    • 84864621308 scopus 로고    scopus 로고
    • Anticholinergic effects in older adults. Weighing the risk-benefit ratio
    • Pollock BG. Anticholinergic effects in older adults. Weighing the risk-benefit ratio. Elder Care 2004;4:5-7.
    • (2004) Elder Care , vol.4 , pp. 5-7
    • Pollock, B.G.1
  • 19
    • 0026266895 scopus 로고
    • Benzodiazepine-induced and anticholinergic-induced delirium in the elderly
    • Tune LE, Bylsma FW. Benzodiazepine-induced and anticholinergic-induced delirium in the elderly. Int Psychogeriatr 1991;3:397-408.
    • (1991) Int Psychogeriatr , vol.3 , pp. 397-408
    • Tune, L.E.1    Bylsma, F.W.2
  • 20
    • 0029071961 scopus 로고
    • Serum anticholinergic activity in hospitalized older persons with delirium: A preliminary study
    • Mach JR Jr, Dysken MW, Kuskowski M et al. Serum anticholinergic activity in hospitalized older persons with delirium: a preliminary study. J Am Geriatr Soc 1995;43:491-5.
    • (1995) J Am Geriatr Soc , vol.43 , pp. 491-495
    • Mach Jr., J.R.1    Dysken, M.W.2    Kuskowski, M.3
  • 22
    • 67349224750 scopus 로고    scopus 로고
    • A preliminary study of anticholinergic burden and relationship to a quality of life indicator, engagement in activities, in nursing home residents with dementia
    • Kolanowski A, Fick DM, Campbell J et al. A preliminary study of anticholinergic burden and relationship to a quality of life indicator, engagement in activities, in nursing home residents with dementia. J Am Med Dir Assoc 2009;10:252-7.
    • (2009) J Am Med Dir Assoc , vol.10 , pp. 252-257
    • Kolanowski, A.1    Fick, D.M.2    Campbell, J.3
  • 23
    • 33750720279 scopus 로고    scopus 로고
    • The anticholinergic drug scale as a measure of drug-related anticholinergic burden: Associations with serum anticholinergic activity
    • DOI 10.1177/0091270006292126
    • Carnahan RM, Lund BC, Perry PJ et al. The anticholinergic drug scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity. J Clin Pharmacol 2006;46:1481-6. (Pubitemid 44704208)
    • (2006) Journal of Clinical Pharmacology , vol.46 , Issue.12 , pp. 1481-1486
    • Carnahan, R.M.1    Lund, B.C.2    Perry, P.J.3    Pollock, B.G.4    Gulp, K.R.5
  • 25
    • 72049093999 scopus 로고    scopus 로고
    • Drug burden index score and functional decline in older people
    • Hilmer SN, Mager DE, Simonsick EM et al. Drug burden index score and functional decline in older people. Am J Med 2009;122(:1142-9.e1-2.
    • (2009) Am J Med , vol.122
    • Hilmer, S.N.1    Mager, D.E.2    Simonsick, E.M.3
  • 26
    • 79959296825 scopus 로고    scopus 로고
    • Potentially inappropriate medications defined by STOPP criteria and the risk of adverse events in older hospitalized patients
    • Hamilton H, Gallagher P, Ryan C et al. Potentially inappropriate medications defined by STOPP criteria and the risk of adverse events in older hospitalized patients. Arch Intern Med 2011;171:1013-9.
    • (2011) Arch Intern Med , vol.171 , pp. 1013-1019
    • Hamilton, H.1    Gallagher, P.2    Ryan, C.3
  • 27
    • 84873613233 scopus 로고    scopus 로고
    • Available at Accessed October 1, 2011
    • Cupp M. PL Detail-Document, STARTing and STOPPing Medications in the Elderly 2011. Available at http://pharmacistsletter.therapeuticresearch.com/pl/ ArticleDD.aspx?cs=FACULTY&s=PL&pt=6&fpt=31&dd=270906&pb= PL&searchid=32337213. Accessed October 1, 2011.
    • (2011) PL Detail-Document, STARTing and STOPPing Medications in the Elderly
    • Cupp, M.1
  • 28
    • 3242675065 scopus 로고    scopus 로고
    • An approach to drug induced delirium in the elderly
    • DOI 10.1136/pgmj.2003.017236
    • Alagiakrishnan K, Wiens CA. Approach to drug induced delirium in the elderly. Postgrad Med J 2004;80:388-93. (Pubitemid 38961859)
    • (2004) Postgraduate Medical Journal , vol.80 , Issue.945 , pp. 388-393
    • Alagiakrishnan, K.1    Wiens, C.A.2
  • 29
    • 79953230462 scopus 로고    scopus 로고
    • Polypharmacy and nutritional status in older adults: A cross-sectional study
    • Heuberger RA, Caudell K. Polypharmacy and nutritional status in older adults: a cross-sectional study. Drugs Aging 2011;28:315-23.
    • (2011) Drugs Aging , vol.28 , pp. 315-323
    • Heuberger, R.A.1    Caudell, K.2
  • 30
    • 0030894452 scopus 로고    scopus 로고
    • Pharmacodynamic and pharmacokinetic considerations in geriatric psychopharmacology
    • DOI 10.1016/S0193-953X(05)70401-9
    • Catterson ML, Preskorn SH, Martin RL. Pharmacodynamic and pharmacokinetic considerations in geriatric psychopharmacology. Psychiatr Clin North Am 1997;20;205-18 (Pubitemid 27118615)
    • (1997) Psychiatric Clinics of North America , vol.20 , Issue.1 , pp. 205-218
    • Catterson, M.L.1    Preskorn, S.H.2    Martin, R.L.3
  • 31
    • 16244374330 scopus 로고    scopus 로고
    • Central nervous system safety of anticholinergic drugs for the treatment of overactive bladder in the elderly
    • DOI 10.1016/j.clinthera.2005.02.014
    • Scheife R, Masayuki T. Central nervous system safety of anticholinergic drugs for the treatment of overactive bladder in the elderly. Clin Ther 2005;27:144-53. (Pubitemid 40462007)
    • (2005) Clinical Therapeutics , vol.27 , Issue.2 , pp. 144-153
    • Scheife, R.1    Takeda, M.2
  • 32
    • 40949126493 scopus 로고    scopus 로고
    • Prescribing for older people
    • DOI 10.1136/bmj.39503.424653.80
    • Milton JC, Hill-Smith I, Jackson SHD. Prescribing for older people. BMJ 2008;336:606-9. (Pubitemid 351439519)
    • (2008) BMJ , vol.336 , Issue.7644 , pp. 606-609
    • Milton, J.C.1    Hill-Smith, I.2    Jackson, S.H.D.3
  • 33
    • 77954743487 scopus 로고    scopus 로고
    • Use of anticholinergics and the risk of cognitive impairment in an African American population
    • Campbell NL, Boustani MA, Lane KA et al. Use of anticholinergics and the risk of cognitive impairment in an African American population. Neurology 2010;75:152-9.
    • (2010) Neurology , vol.75 , pp. 152-159
    • Campbell, N.L.1    Boustani, M.A.2    Lane, K.A.3
  • 34
    • 67749103704 scopus 로고    scopus 로고
    • Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population
    • Carriere I, Fourrier-Reglat A, Dartigues JF et al. Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population. Arch Intern Med 2009;169:1317-24.
    • (2009) Arch Intern Med , vol.169 , pp. 1317-1324
    • Carriere, I.1    Fourrier-Reglat, A.2    Dartigues, J.F.3
  • 35
    • 78649361540 scopus 로고    scopus 로고
    • Prevalence and predictors of anticholinergic medication use in elderly nursing home residents with dementia: Analysis of data from the 2004 National Nursing Home Survey
    • Chatterjee S, Mehta S, Sherer JT et al. Prevalence and predictors of anticholinergic medication use in elderly nursing home residents with dementia: analysis of data from the 2004 National Nursing Home Survey. Drugs Aging 2010;27:987-97.
    • (2010) Drugs Aging , vol.27 , pp. 987-997
    • Chatterjee, S.1    Mehta, S.2    Sherer, J.T.3
  • 36
    • 25444435011 scopus 로고    scopus 로고
    • Preventing delirium in older people
    • DOI 10.1093/bmb/ldh048
    • Anderson D. Preventing delirium in older people. Br Med Bull 2005;73:25-34. (Pubitemid 43020356)
    • (2005) British Medical Bulletin , vol.73-74 , pp. 25-34
    • Anderson, D.1
  • 37
    • 0034920302 scopus 로고    scopus 로고
    • Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients
    • Han L, McCusker J, Cole M et al. Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients. Arch Intern Med 2001;161:1099-105. (Pubitemid 32685536)
    • (2001) Archives of Internal Medicine , vol.161 , Issue.8 , pp. 1099-1105
    • Han, L.1    McCusker, J.2    Cole, M.3    Abrahamowicz, M.4    Primeau, F.5    Elie, M.6
  • 38
    • 32344443801 scopus 로고    scopus 로고
    • Can olanzapine cause delirium in the elderly?
    • DOI 10.1345/aph.1G318
    • Lim CJ, Trevino C, Tampi RR. Can olanzapine cause delirium in the elderly? Ann Pharmacother 2006;40:135-8. (Pubitemid 43221486)
    • (2006) Annals of Pharmacotherapy , vol.40 , Issue.1 , pp. 135-138
    • Lim, C.J.1    Trevino, C.2    Tampi, R.R.3
  • 39
    • 80855132558 scopus 로고    scopus 로고
    • Hot, blind, and mad: Avoidable geriatric anticholinergic delirium
    • Mar 31 Epub ahead of print
    • Ochs KL, Zell-Kanter M, Mycyk MB. Hot, blind, and mad: avoidable geriatric anticholinergic delirium. Am J Emerg Med 2011;Mar 31 [Epub ahead of print].
    • (2011) Am J Emerg Med
    • Ochs, K.L.1    Zell-Kanter, M.2    Mycyk, M.B.3
  • 41
    • 0032430554 scopus 로고    scopus 로고
    • The reliability and validity of a new measure of severity of delirium
    • McCusker J, Cole M, Bellavance F et al. The reliability and validity of a new measure of severity of delirium. Int Psychogeriatr 1998;10:303-8.
    • (1998) Int Psychogeriatr , vol.10 , pp. 303-308
    • McCusker, J.1    Cole, M.2    Bellavance, F.3
  • 42
    • 33644776510 scopus 로고    scopus 로고
    • Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: Longitudinal cohort study
    • Ancelin ML, Artero S, Portet F et al. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ 2006;332:455-9.
    • (2006) BMJ , vol.332 , pp. 455-459
    • Ancelin, M.L.1    Artero, S.2    Portet, F.3
  • 43
    • 76549126343 scopus 로고    scopus 로고
    • Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: A cohort study
    • Ehrt U, Broich K, Petter JP et al. Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: a cohort study. J Neurol Neurosurg Psychiatry 2010;81:160-5.
    • (2010) J Neurol Neurosurg Psychiatry , vol.81 , pp. 160-165
    • Ehrt, U.1    Broich, K.2    Petter, J.P.3
  • 44
    • 47949098266 scopus 로고    scopus 로고
    • The effects of antimuscarinic treatments in overactive bladder: An update of a systematic review and meta-analysis
    • Epub 2008 Jun 20
    • Chapple CR, Khullar V, Gabriel Z et al. The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis. Eur Urol 2008;54:543-62 [Epub 2008 Jun 20].
    • (2008) Eur Urol , vol.54 , pp. 543-562
    • Chapple, C.R.1    Khullar, V.2    Gabriel, Z.3
  • 46
    • 80052006496 scopus 로고    scopus 로고
    • Drugs with anticholinergic properties: A current perspective on use and safety
    • Gerretsen P, Pollock BG. Drugs with anticholinergic properties: a current perspective on use and safety. Expert Opin Drug Saf 2011;10:751-65.
    • (2011) Expert Opin Drug Saf , vol.10 , pp. 751-765
    • Gerretsen, P.1    Pollock, B.G.2
  • 47
    • 77955247789 scopus 로고    scopus 로고
    • Trospium chloride is undetectable in the older human central nervous system
    • Staskin D, Kay G, Tannenbaum C et al. Trospium chloride is undetectable in the older human central nervous system. J Am Geriatr Soc 2010;58:1618-9.
    • (2010) J Am Geriatr Soc , vol.58 , pp. 1618-1619
    • Staskin, D.1    Kay, G.2    Tannenbaum, C.3
  • 48
    • 77954647114 scopus 로고    scopus 로고
    • Trospium chloride has no effect on memory testing and is assay undetectable in the CNS of older patients with overactive bladder
    • Staskin D, Kay G, Tannenbaum C et al. Trospium chloride has no effect on memory testing and is assay undetectable in the CNS of older patients with overactive bladder. Int J Clin Pract 2010;64:1294-300.
    • (2010) Int J Clin Pract , vol.64 , pp. 1294-1300
    • Staskin, D.1    Kay, G.2    Tannenbaum, C.3
  • 49
    • 79952572378 scopus 로고    scopus 로고
    • Evaluation of brain anticholinergic activities of urinary spasmolytic drugs using a highthroughput radio receptor bioassay
    • Jakobsen SM, Kersten H, Molden E. Evaluation of brain anticholinergic activities of urinary spasmolytic drugs using a highthroughput radio receptor bioassay. J Am Geriatr Soc 2011;59:501-5.
    • (2011) J Am Geriatr Soc , vol.59 , pp. 501-505
    • Jakobsen, S.M.1    Kersten, H.2    Molden, E.3
  • 50
    • 33646170231 scopus 로고    scopus 로고
    • Constipation in older patients: Effects on quality of life
    • Norton C. Constipation in older patients: effects on quality of life. Br J Nurs 2006;15:188-92.
    • (2006) Br J Nurs , vol.15 , pp. 188-192
    • Norton, C.1
  • 51
    • 33847262167 scopus 로고    scopus 로고
    • Use of laxatives among older nursing home residents in Helsinki, Finland
    • DOI 10.2165/00002512-200724020-00006
    • Hosia-Randell H, Suominen M, Muurinen S et al. Use of laxatives among older nursing home residents in Helsinki, Finland. Drugs Aging 2007;24:147-54. (Pubitemid 46327573)
    • (2007) Drugs and Aging , vol.24 , Issue.2 , pp. 147-154
    • Hosia-Randell, H.1    Suominen, M.2    Muurinen, S.3    Pitkala, K.H.4
  • 52
    • 0035033062 scopus 로고    scopus 로고
    • Tolterodine: A review of its use in the treatment of overactive bladder
    • Clemett D, Jarvis B. Tolterodine: a review of its use in the treatment of overactive bladder. Drugs Aging 2001;18:277-304. (Pubitemid 32391815)
    • (2001) Drugs and Aging , vol.18 , Issue.4 , pp. 277-304
    • Clemett, D.1    Jarvis, B.2
  • 53
    • 0035126767 scopus 로고    scopus 로고
    • Tolterodine once-daily: Superior efficacy and tolerability in the treatment of the overactive bladder
    • DOI 10.1016/S0090-4295(00)01113-4, PII S0090429500011134
    • Van Kerrebroeck P, Kreder K, Jonas U et al. Tolerotidine once daily: superior efficacy and tolerability in the treatment of overactive bladder. Urology 2001;57:414-21. (Pubitemid 32192963)
    • (2001) Urology , vol.57 , Issue.3 , pp. 414-421
    • Van Kerrebroeck, P.1    Kreder, K.2    Jonas, U.3    Zinner, N.4    Wein, A.5
  • 54
    • 0037905794 scopus 로고    scopus 로고
    • Prospective, randomized, double-blind study of the efficacy and tolerability of the extended-release formulations of oxybutynin and tolterodine for overactive bladder: Results of the OPERA trial
    • Diokno AC, Appell RA, Sand PK et al. Prospective, randomized, double-blind study of the efficacy and tolerability of the extendedrelease formulations of oxybutynin and tolterodine for overactive bladder: results of the OPERA trial. Mayo Clin Proc 2003;78:687-95. (Pubitemid 36665898)
    • (2003) Mayo Clinic Proceedings , vol.78 , Issue.6 , pp. 687-695
    • Diokno, A.C.1    Appell, R.A.2    Sand, P.K.3    Dmochowski, R.R.4    Gburek, B.M.5    Klimberg, I.W.6    Kell, S.H.7
  • 55
    • 0642367799 scopus 로고    scopus 로고
    • Update on overactive bladder: Pharmacologic approaches on the horizon
    • Rovner ES, Wein AJ. Update on overactive bladder: pharmacologic approaches on the horizon. Curr Urol Rap 2003;4:385-90.
    • (2003) Curr Urol Rap , vol.4 , pp. 385-390
    • Rovner, E.S.1    Wein, A.J.2
  • 56
    • 0141566414 scopus 로고    scopus 로고
    • Controlled, double-blind, multicentre clinical trial to investigate long-term tolerability and efficacy of trospium chloride in patients with detrusor instability
    • DOI 10.1007/s00345-003-0321-8
    • Hoflner K, Halaska M, Primus C et al. Tolerability and efficacy of trospium chloride in a long-term treatment (52 weeks) in patients with urge syndrome: a double-blind, controlled multicentre clinical trial. World J Urol. 2003;20:392-9. (Pubitemid 44175311)
    • (2003) World Journal of Urology , vol.20 , Issue.6 , pp. 392-399
    • Halaska, M.1    Ralph, G.2    Wiedemann, A.3    Primus, G.4    Ballering-Bruhl, B.5    Hofner, K.6    Jonas, U.7
  • 57
    • 1642276168 scopus 로고    scopus 로고
    • Darifenacin, an M3 selective receptor antagonist, is an effective and well-tolerated once-daily treatment for overactive bladder
    • Haab F, Stewart L, Dwyer P. Darifenacin, an M3 selective receptor antagonist, is an effective and well-tolerated once-daily treatment for overactive bladder. Eur Urol 2004;45:420.
    • (2004) Eur Urol , vol.45 , pp. 420
    • Haab, F.1    Stewart, L.2    Dwyer, P.3
  • 58
    • 23944452838 scopus 로고    scopus 로고
    • A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome: Results of the STAR trial
    • Chapple CR, Martinez-Garcia R, Selvaggi L et al. A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome: results of the STAR trial. Eur Urol 2005;48:464.
    • (2005) Eur Urol , vol.48 , pp. 464
    • Chapple, C.R.1    Martinez-Garcia, R.2    Selvaggi, L.3
  • 59
    • 33644846418 scopus 로고    scopus 로고
    • Efficacy, tolerability and safety of darifenacin, an M(3) selective receptor antagonist: An investigation of warning time in patients with OAB
    • Zinner N, Susset J, Gittelman M et al. Efficacy, tolerability and safety of darifenacin, an M(3) selective receptor antagonist: an investigation of warning time in patients with OAB. Int J Clin Pract 2006;60:119.
    • (2006) Int J Clin Pract , vol.60 , pp. 119
    • Zinner, N.1    Susset, J.2    Gittelman, M.3
  • 60
    • 33845938174 scopus 로고    scopus 로고
    • Pooled clinical trial analysis of tiotropium safety
    • DOI 10.1378/chest.130.6.1695
    • Kesten S, Jara M, Wentworth C et al. Pooled clinical trial analysis of tiotropium safety. Chest 2006;130:1695-703. (Pubitemid 46033421)
    • (2006) Chest , vol.130 , Issue.6 , pp. 1695-1703
    • Kesten, S.1    Jara, M.2    Wentworth, C.3    Lanes, S.4
  • 61
    • 84856118942 scopus 로고    scopus 로고
    • Tiotropium bromide inhalation powder: A review of its use in the management of chronic obstructive pulmonary disease
    • Jan 4 Epub ahead of print
    • Keating GM. Tiotropium bromide inhalation powder: a review of its use in the management of chronic obstructive pulmonary disease. Drugs 2012 Jan 4 [Epub ahead of print].
    • (2012) Drugs
    • Keating, G.M.1
  • 62
    • 79955664791 scopus 로고    scopus 로고
    • Tiotropium for treatment of stable COPD: A meta-analysis of clinically relevant outcomes
    • Yohannes AM, Willgoss TG, Vestbo J. Tiotropium for treatment of stable COPD: a meta-analysis of clinically relevant outcomes. Respir Care 2011;56:477-87.
    • (2011) Respir Care , vol.56 , pp. 477-487
    • Yohannes, A.M.1    Willgoss, T.G.2    Vestbo, J.3
  • 63
  • 64
    • 79957542665 scopus 로고    scopus 로고
    • Inhaled anticholinergic drug therapy and the risk of acute urinary retention in chronic obstructive pulmonary disease
    • Stephenson A, Seitz D, Bell CM et al. Inhaled anticholinergic drug therapy and the risk of acute urinary retention in chronic obstructive pulmonary disease. Arch Intern Med 2011;171:914-20.
    • (2011) Arch Intern Med , vol.171 , pp. 914-920
    • Stephenson, A.1    Seitz, D.2    Bell, C.M.3
  • 65
    • 78650710070 scopus 로고    scopus 로고
    • Iatrogenic glaucoma secondary to mediations
    • Razeqhinejad MR, Myers JS, Katz LJ. Iatrogenic glaucoma secondary to mediations. Am J Med 2011;124:20-5.
    • (2011) Am J Med , vol.124 , pp. 20-25
    • Razeqhinejad, M.R.1    Myers, J.S.2    Katz, L.J.3
  • 71
    • 0030802061 scopus 로고    scopus 로고
    • Explicit criteria for determining potentially inappropriate medication use by the elderly an update
    • Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly: an update. Arch Intern Med 1997;157:1531-6. (Pubitemid 27305197)
    • (1997) Archives of Internal Medicine , vol.157 , Issue.14 , pp. 1531-1536
    • Beers, M.H.1
  • 72
    • 0035899831 scopus 로고    scopus 로고
    • Quality indicators for appropriate medication use in vulnerable elders
    • Knight EL, Avorn J. Quality indicators for appropriate medication use in vulnerable elders. Ann Intern Med 2001;135:703-10. (Pubitemid 33015483)
    • (2001) Annals of Internal Medicine , vol.135 , Issue.8 I , pp. 703-710
    • Knight, E.L.1    Avorn, J.2
  • 73
    • 0025878943 scopus 로고
    • The relationship of serum anticholinergic activity to mental status performance in an elderly nursing home population
    • Tollefson GD, Montague-Clouse J, Lancaster SP. The relationship of serum anticholinergic activity to mental status performance in an elderly nursing home population. J Neuropsychiatry Clin Neurosci 1991;3:314-9.
    • (1991) J Neuropsychiatry Clin Neurosci , vol.3 , pp. 314-319
    • Tollefson, G.D.1    Montague-Clouse, J.2    Lancaster, S.P.3
  • 74
    • 77149121760 scopus 로고    scopus 로고
    • Drug burden index and potentially inappropriate medications in community-dwelling older people
    • Castelino RL, Hilmer SN, Bajorek BV et al. Drug burden index and potentially inappropriate medications in community-dwelling older people. Drugs Aging 2010;27:135-48.
    • (2010) Drugs Aging , vol.27 , pp. 135-148
    • Castelino, R.L.1    Hilmer, S.N.2    Bajorek, B.V.3
  • 75
    • 69049115213 scopus 로고    scopus 로고
    • Impact of residential medication management reviews on drug burden index in aged-care homes
    • Nishtala PS, Hilmer SN, McLachlan AJ et al. Impact of residential medication management reviews on drug burden index in aged-care homes. Drugs Aging 2009;26:677-86.
    • (2009) Drugs Aging , vol.26 , pp. 677-686
    • Nishtala, P.S.1    Hilmer, S.N.2    McLachlan, A.J.3
  • 76
    • 77749258872 scopus 로고    scopus 로고
    • Medication nonadherence secondary to drug-induced memory loss
    • Nye AM, Clinard VB, Barnes CL. Medication nonadherence secondary to drug-induced memory loss. Consult Pharm 2010;25:117-21.
    • (2010) Consult Pharm , vol.25 , pp. 117-121
    • Nye, A.M.1    Clinard, V.B.2    Barnes, C.L.3
  • 78
    • 84864582268 scopus 로고    scopus 로고
    • Available at Accessed October 1, 2011
    • Scott GN, Cupp M. Potentially harmful drugs in the elderly: Beers list and more 2007. Available at http://pharmacistsletter.therapeuticresearch.com/pl/ ArticleDD.aspx?nidchk=1&cs=FACULTY&s=PL&pt=6&fpt=31&dd= 230907&pb=PL&searchid=32337165. Accessed October 1, 2011.
    • (2007) Potentially Harmful Drugs in the Elderly: Beers List and More
    • Scott, G.N.1    Cupp, M.2
  • 79
    • 33646803001 scopus 로고    scopus 로고
    • Anticholinergic medications in community-dwelling older veterans: Prevalence of anticholinergic symptoms, symptom burden, and adverse drug events
    • Ness J, Hoth A, Barnett MJ et al. Anticholinergic medications in community-dwelling older veterans: prevalence of anticholinergic symptoms, symptom burden, and adverse drug events. Am J Geriatr Pharmacother 2006;4:42-51.
    • (2006) Am J Geriatr Pharmacother , vol.4 , pp. 42-51
    • Ness, J.1    Hoth, A.2    Barnett, M.J.3
  • 81
    • 41949083073 scopus 로고    scopus 로고
    • The anticholinergic risk scale and anticholinergic adverse effects in older persons
    • DOI 10.1001/archinternmed.2007.106
    • Rudolph JL, Salow MJ, Angelini MC et al. The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med 2008;168:508-13. (Pubitemid 351547214)
    • (2008) Archives of Internal Medicine , vol.168 , Issue.5 , pp. 508-513
    • Rudolph, J.L.1    Salow, M.J.2    Angelini, M.C.3    McGlinchey, R.E.4
  • 82
    • 0036759078 scopus 로고    scopus 로고
    • Anticholinergic burden and the risk of falls among elderly psychiatric inpatients: A 4-year case-control study
    • DOI 10.1017/S1041610202008505
    • Aizenberg D, Sigler M, Weizman A et al. Anticholinergic burden and the risk of falls among elderly psychiatric inpatients: a 4-year case-control study. Int Psychogeriatr 2002;14:307-10. (Pubitemid 35375545)
    • (2002) International Psychogeriatrics , vol.14 , Issue.3 , pp. 307-310
    • Aizenberg, D.1    Sigler, M.2    Weizman, A.3    Barak, Y.4
  • 83
    • 57149143738 scopus 로고    scopus 로고
    • Cumulative anticholinergic exposure is associated with poor memory and executive function in older men
    • Han L, Agostini JV, Allore HG. Cumulative anticholinergic exposure is associated with poor memory and executive function in older men. J Am Geriatr Soc 2008;56:2203-10.
    • (2008) J Am Geriatr Soc , vol.56 , pp. 2203-2210
    • Han, L.1    Agostini, J.V.2    Allore, H.G.3
  • 84
    • 0030684063 scopus 로고    scopus 로고
    • Optimising drug treatment for elderly people: The prescribing cascade
    • Rochon PA, Gurwitz JH. Optimising drug treatment for elderly people: the prescribing cascade. BMJ 1997;315:1096.
    • (1997) BMJ , vol.315 , pp. 1096
    • Rochon, P.A.1    Gurwitz, J.H.2
  • 85
    • 34447308781 scopus 로고    scopus 로고
    • Appropriate prescribing in elderly people: how well can it be measured and optimised?
    • DOI 10.1016/S0140-6736(07)61091-5, PII S0140673607610915
    • Spinewine A, Schmader KE, Barber N et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 2007;370:173-84. (Pubitemid 47049724)
    • (2007) Lancet , vol.370 , Issue.9582 , pp. 173-184
    • Spinewine, A.1    Schmader, K.E.2    Barber, N.3    Hughes, C.4    Lapane, K.L.5    Swine, C.6    Hanlon, J.T.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.